---
title: "HRPC released its performance for the first half of the year, with a net profit attributable to the parent company of 72.5792 million yuan, a decrease of 46.31%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/252183653.md"
description: "HRPC released its semi-annual report for 2025, with operating revenue of 479 million yuan, a year-on-year decrease of 90.39%. The net profit attributable to shareholders was 72.5792 million yuan, a year-on-year decline of 46.31%. The net profit after deducting non-recurring gains and losses was 72.4414 million yuan, a year-on-year decrease of 41.20%. The basic earnings per share were 0.1252 yuan. The decline in net profit was mainly due to a decrease in gross profit, changes in sales, and an increase in the provision for bad debts of accounts receivable"
datetime: "2025-08-08T08:39:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/252183653.md)
  - [en](https://longbridge.com/en/news/252183653.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/252183653.md)
---

# HRPC released its performance for the first half of the year, with a net profit attributable to the parent company of 72.5792 million yuan, a decrease of 46.31%

According to the Zhitong Finance APP, HRPC (600829.SH) released its semi-annual report for 2025, showing that the company's operating revenue was 479 million yuan, a year-on-year decrease of 90.39%. The net profit attributable to shareholders of the listed company was 72.5792 million yuan, a year-on-year decrease of 46.31%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 72.4414 million yuan, a year-on-year decrease of 41.20%. The basic earnings per share were 0.1252 yuan.

The main reasons for the year-on-year decrease in net profit attributable to shareholders of the listed company during the reporting period are: first, the decrease in gross profit, mainly due to the continued impact of centralized procurement policies on the wholesale sector, leading to lower drug prices and tighter gross profit margins; second, changes in sales affecting related operating expenses; third, an increase in the provision for bad debts on accounts receivable based on changes in the aging of accounts receivable

### Related Stocks

- [600829.CN](https://longbridge.com/en/quote/600829.CN.md)

## Related News & Research

- [FACTBOX-Here are the Democrats taking early steps in potential 2028 White House bids](https://longbridge.com/en/news/286890348.md)
- [IRAN'S ISNA NEWS AGENCY SAYS IRAN 'IS RESPONDING TO A TEXT SENT BY THE U.S.'](https://longbridge.com/en/news/287185225.md)
- [Martin Lewis tells households to act now over hidden energy refunds](https://longbridge.com/en/news/287089299.md)
- [Senate Democrats call for White House election security czar's removal](https://longbridge.com/en/news/286956776.md)
- [Obamacare Meltdown? Sharp ACA Enrollment Drop Expected As Pandemic-Era Subsidies End](https://longbridge.com/en/news/287067300.md)